ARCHIVES

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

This article is from The Cancer Letter archive.

Vol. 31 No. 38 | October 21, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Programs: Genetic Variations Discovered, Added to NCI Database

June 11, 1999

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

March 28, 2008

In Brief: Cancer Research Institute to Support AIDS Grants, With Maximum $70,000 Each; Deadline Is Oct. 1

July 15, 1983

Organ Systems Program Defenders Go On Offense At NCAB Committee Meeting

December 11, 1987

FDA Rile Changes Reporting Requirements for Adverse Events

November 18, 1994

Reports On Nutrition & Cancer Show Needs For More Clinical Studies

September 5, 1975